P53 alteration and microsatellite instability have predictive value for survival benefit from chemotherapy in stage III colorectal carcinoma

Clinical Cancer Research

Volumn 7, Issue 5, 2001, Pages 1343-1349

  Elsaleh, Hany ^a,b   Powell, Brenda ^b   McCaul, Kieran ^b   Grieu, Fabienne ^a   Grant, Ryan ^b   Joseph, David ^a,b   Iacopetta, Barry ^b  

^a SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; LEVAMISOLE; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

ADULT; AGED; COLORECTAL NEOPLASMS; FEMALE; GENETIC MARKERS; HUMANS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUTATION; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034895979     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: A final report
2. Evidence for tumor site and gender specific survival benefit from adjuvant chemotherapy in colorectal cancer
3. Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapy
4. The clinical significance of p53 aberrations in human tumors
5. p53 status and the efficacy of cancer therapy in vivo
6. Disruption of p53 in human cancer cells alters the responses to therapeutic agents
7. Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents
8. p53 point mutation and survival in colorectal cancer patients
9. p53 mutations as a possible predictor of response to chemotherapy in metastatic colorectal carcinomas
10. Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: A Southwest Oncology Group study
11. p53 alterations are associated with improved prognosis in distal colonic carcinomas
12. Comparison of p53 gene mutation and protein overexpression in colorectal carcinomas
13. A rapid and nonisotopic method for the screening and sequencing of p53 gene mutations in formalin-fixed, paraffin-embedded tumors
14. Routine analysis of p53 mutation in clinical breast tumor specimens using fluorescence-based polymerase chain reaction and single-strand conformation polymorphism
15. Relative efficiency of denaturing gradient gel electrophoresis and single-strand conformation polymorphism in the detection of mutations in exons 5 to 8 of the p53 gene
16. Rapid and nonisotopic SSCP-based analysis of the BAT-26 mononucleotide repeat for identification of the replication error phenotype in human cancers
17. Determination of the replication error phenotype in human tumors without the requirement for matching normal DNA by analysis of mononucleotide repeat microsatellites
18. Association of p53 mutations with short survival in colorectal cancer
19. p53 point mutation and survival in colorectal cancer patients: Effect of disease dissemination and tumour location
20. Prognostic value of p53 genetic changes in colorectal cancer
21. p53 and K-ras gene mutations correlate with tumor aggressiveness but are not of routine prognostic value in colorectal cancer
22. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis
23. Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences
24. Inverse correlation between RER+ status and p53 mutation in colorectal cancer cell lines
25. Genomic instability in colorectal cancer: Relationship to clinicopathological variables and family history
26. Colorectal cancer: Evidence for distinct genetic categories based on proximal or distal tumor location
27. Multiple genetic alterations in distal and proximal colorectal cancer
28. Aberrant methylation of p16INK4a in anatomic and gender-specific subtypes of sporadic colorectal cancer
29. Late onset and high incidence of colon cancer of the mutator phenotype with hypermethylated hMLH1 gene in women
30. Defining the optimal therapy for rectal cancer
31. Specific p53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients
32. p53 gene status as a predictor of tumor response to induction chemotherapy of patients with locoregionally advanced squamous cell carcinomas of the head and neck
33. CpG island methylator phenotype in colorectal cancer
34. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines
35. Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer
36. p53 sequence analysis predicts treatment response and outcome of patients with esophageal carcinoma